{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T20:55:25Z","timestamp":1778187325725,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803836"],"award-info":[{"award-number":["81803836"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010265","name":"Guizhou Medical University","doi-asserted-by":"publisher","award":["FAMP201708K"],"award-info":[{"award-number":["FAMP201708K"]}],"id":[{"id":"10.13039\/501100010265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFC1602405"],"award-info":[{"award-number":["2018YFC1602405"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.toxlet.2021.02.008","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T07:45:34Z","timestamp":1613547934000},"page":"85-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Triptolide and atorvastatin synergistically promote hepatotoxicity in cultured hepatocytes and female Sprague-Dawley rats by inhibiting pregnane X receptor-mediated transcriptional activation of CYP3A4"],"prefix":"10.1016","volume":"342","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3565-3100","authenticated-orcid":false,"given":"Nan","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aili","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0699-7679","authenticated-orcid":false,"given":"Lili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2021.02.008_bib0005","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.phytochem.2006.11.029","article-title":"Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae)","volume":"68","author":"Brinker","year":"2007","journal-title":"Phytochemistry"},{"key":"10.1016\/j.toxlet.2021.02.008_bib0010","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1517\/17425255.2013.754010","article-title":"Nuclear receptors PXR and CAR: implications for drug metabolism regulation, pharmacogenomics and beyond","volume":"9","author":"Chai","year":"2013","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0015","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/10428190109064582","article-title":"Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium wilfordii Hook F","volume":"42","author":"Chen","year":"2001","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.toxlet.2021.02.008_bib0020","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1101\/gad.246173.114","article-title":"Stably paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor triptolide","volume":"29","author":"Chen","year":"2015","journal-title":"Genes Dev."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0025","article-title":"A mechanistic overview of triptolide and celastrol, natural products from Tripterygium wilfordii hook F","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0030","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0002-9343(01)00870-1","article-title":"Clinically relevant differences between the statins: implications for therapeutic selection","volume":"111","author":"Chong","year":"2001","journal-title":"Am. J. Med."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0035","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0040","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/cbic.201100007","article-title":"Triptolide directly inhibits dCTP pyrophosphatase","volume":"12","author":"Corson","year":"2011","journal-title":"Chembiochem"},{"key":"10.1016\/j.toxlet.2021.02.008_bib0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19020376","article-title":"The effect of triptolide in rheumatoid arthritis: from basic research towards clinical translation","volume":"19","author":"Fan","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0050","series-title":"The Cytotoxic Effect of 2-Deoxy-D-Glucose Combination With 5- Fluorourasil and NO-Aspirin on Mammary Adenocacinoma Cell Line","author":"G.Al-Jassim","year":"2014"},{"key":"10.1016\/j.toxlet.2021.02.008_bib0055","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00204-019-02426-5","article-title":"An effective antidotal combination of polymyxin B and methylprednisolone for alpha-amanitin intoxication","volume":"93","author":"Garcia","year":"2019","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0060","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1517\/14728222.8.1.49","article-title":"Orphan nuclear receptors, PXR and LXR: new ligands and therapeutic potential","volume":"8","author":"Gong","year":"2004","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.toxlet.2021.02.008_bib0065","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2125.2012.04221.x","article-title":"Triptolide in the treatment of psoriasis and other immune-mediated inflammatory diseases","volume":"74","author":"Han","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0070","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1124\/dmd.117.076539","article-title":"Successful prediction of in vivo hepatobiliary clearances and hepatic concentrations of rosuvastatin using sandwich-cultured rat hepatocytes, transporter-expressing cell lines, and quantitative proteomics","volume":"46","author":"Ishida","year":"2018","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0075","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1210\/er.2001-0038","article-title":"The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism","volume":"23","author":"Kliewer","year":"2002","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0080","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.phytochem.2010.10.015","article-title":"Molecular analyses of the Chinese herb Leigongteng (Tripterygium wilfordii Hook.f.)","volume":"72","author":"Law","year":"2011","journal-title":"Phytochemistry"},{"key":"10.1016\/j.toxlet.2021.02.008_bib0085","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2165\/00003088-200342130-00005","article-title":"Clinical pharmacokinetics of atorvastatin","volume":"42","author":"Lennernas","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0090","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1073\/pnas.0700499104","article-title":"Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease","volume":"104","author":"Leuenroth","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0095","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jep.2014.06.006","article-title":"Triptolide: progress on research in pharmacodynamics and toxicology","volume":"155","author":"Li","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0100","doi-asserted-by":"crossref","first-page":"34572","DOI":"10.1039\/C4RA17009A","article-title":"Computational prediction and experimental validation of low-affinity target of triptolide and its analogues","volume":"5","author":"Liu","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0105","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.chembiol.2013.12.009","article-title":"TAB1: a target of triptolide in macrophages","volume":"21","author":"Lu","year":"2014","journal-title":"Chem. Biol."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0110","doi-asserted-by":"crossref","DOI":"10.1186\/s12906-016-1504-3","article-title":"Triptolide induces hepatotoxicity via inhibition of CYP450s in Rat liver microsomes","volume":"17","author":"Lu","year":"2017","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0115","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.phytochem.2007.02.021","article-title":"Anti-inflammatory and immunosuppressive compounds from Tripterygium wilfordii","volume":"68","author":"Ma","year":"2007","journal-title":"Phytochemistry"},{"key":"10.1016\/j.toxlet.2021.02.008_bib0120","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1158\/0008-5472.CAN-12-1006","article-title":"Natural product triptolide mediates Cancer cell death by triggering CDK7-Dependent degradation of RNA polymerase II","volume":"72","author":"Manzo","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0125","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1158\/0008-5472.CAN-12-1006","article-title":"Natural product triptolide mediates cancer cell death by triggering CDK7-dependent degradation of RNA polymerase II","volume":"72","author":"Manzo","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0130","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.phrs.2004.10.007","article-title":"The research on the anti-inflammatory activity and hepatotoxicity of triptolide-loaded solid lipid nanoparticle","volume":"51","author":"Mei","year":"2005","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0135","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cld.2019.09.007","article-title":"Drug-induced liver injury from statins","volume":"24","author":"Meurer","year":"2020","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0140","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.tips.2019.03.002","article-title":"Triptolide and its derivatives as cancer therapies","volume":"40","author":"Noel","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0145","doi-asserted-by":"crossref","DOI":"10.11131\/2015\/101178","article-title":"Nuclear receptors in drug metabolism, drug response and drug interactions","volume":"2","author":"Prakash","year":"2015","journal-title":"Nucl. Receptor Res."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0150","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jep.2015.05.010","article-title":". Integrated targeted sphingolipidomics and transcriptomics reveal abnormal sphingolipid metabolism as a novel mechanism of the hepatotoxicity and nephrotoxicity of triptolide","volume":"170","author":"Qu","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0155","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.fct.2014.05.020","article-title":"Role of CYP3A in regulating hepatic clearance and hepatotoxicity of triptolide in rat liver microsomes and sandwich-cultured hepatocytes","volume":"71","author":"Shen","year":"2014","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/03602532.2012.743560","article-title":"Evaluation of pregnane X receptor (PXR)-mediated CYP3A4 drug-drug interactions in drug development","volume":"45","author":"Sinz","year":"2013","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0165","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1177\/106002809502900612","article-title":"Recent advances: the cytochrome P450 enzymes","volume":"29","author":"Slaughter","year":"1995","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0170","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1038\/oncsis.2015.10","article-title":"Human dCTP pyrophosphatase 1 promotes breast cancer cell growth and stemness through the modulation on 5-methyl-dCTP metabolism and global hypomethylation","volume":"4","author":"Song","year":"2015","journal-title":"Oncogenesis"},{"key":"10.1016\/j.toxlet.2021.02.008_bib0175","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.4161\/cbt.8.21.9803","article-title":"Triptolide: an inhibitor of a disintegrin and metalloproteinase 10 (ADAM10) in cancer cells","volume":"8","author":"Soundararajan","year":"2009","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0180","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nchembio.522","article-title":"XPB, a subunit of TFIIH, is a target of the natural product triptolide","volume":"7","author":"Titov","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0185","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1046\/j.1440-1797.2003.00143.x","article-title":"Atorvastatin in dyslipidaemia of the nephrotic syndrome","volume":"8","author":"Valdivielso","year":"2003","journal-title":"Nephrology"},{"key":"10.1016\/j.toxlet.2021.02.008_bib0190","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1517\/14656566.6.7.1191","article-title":"Atorvastatin","volume":"6","author":"van Leuven","year":"2005","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0195","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.tem.2009.03.003","article-title":"PXR and CAR in energy metabolism","volume":"20","author":"Wada","year":"2009","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0200","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.tem.2009.03.003","article-title":"PXR and CAR in energy metabolism","volume":"20","author":"Wada","year":"2009","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0205","article-title":"Triptolide (TPL) inhibits global transcription by inducing proteasome-dependent degradation of RNA polymerase II (Pol II)","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.toxlet.2021.02.008_bib0210","article-title":"Traditional chinese medicine for refractory nephrotic syndrome: strategies and promising treatments","volume":"2018","author":"Wang","year":"2018","journal-title":"Evid. Complement. Alternat. Med."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0215","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF02836473","article-title":"Clinical observation on effect of triptolide tablet in treating patients with psoriasis vulgaris","volume":"11","author":"Wu","year":"2005","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0220","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.biopha.2017.04.003","article-title":"Toxicity of triptolide and the molecular mechanisms involved","volume":"90","author":"Xi","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0225","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3109\/00498254.2015.1020076","article-title":"Involvement of CAR and PXR in the transcriptional regulation of CYP2B6 gene expression by ingredients from herbal medicines","volume":"45","author":"Xu","year":"2015","journal-title":"Xenobiotica"},{"key":"10.1016\/j.toxlet.2021.02.008_bib0230","first-page":"65","article-title":"Triptolide inhibits the growth and metastasis of solid tumors","volume":"2","author":"Yang","year":"2003","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0235","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.cbi.2008.08.013","article-title":"PXR-mediated transcriptional activation of CYP3A4 by cryptotanshinone and tanshinone IIA","volume":"177","author":"Yu","year":"2009","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105754","article-title":"The role of inflammasome activation in Triptolide-induced acute liver toxicity","volume":"75","author":"Yuan","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0245","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/jat.3821","article-title":"High-content analysis boosts identification of the initial cause of triptolide-induced hepatotoxicity","volume":"39","author":"Zheng","year":"2019","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.toxlet.2021.02.008_bib0250","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1124\/dmd.113.054056","article-title":"Assessment of the roles of P-glycoprotein and cytochrome P450 in triptolide-induced liver toxicity in sandwich-cultured rat hepatocyte model","volume":"41","author":"Zhuang","year":"2013","journal-title":"Drug Metab. Dispos."}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427421000485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427421000485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T05:22:29Z","timestamp":1759900949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427421000485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":50,"alternative-id":["S0378427421000485"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2021.02.008","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triptolide and atorvastatin synergistically promote hepatotoxicity in cultured hepatocytes and female Sprague-Dawley rats by inhibiting pregnane X receptor-mediated transcriptional activation of CYP3A4","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2021.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}